Logo image of HCTI

HEALTHCARE TRIANGLE INC (HCTI) Stock Fundamental Analysis

NASDAQ:HCTI - Nasdaq - US42227W2070 - Common Stock - Currency: USD

0.395  -0.11 (-21.47%)

After market: 0.3971 +0 (+0.53%)

Fundamental Rating

1

Taking everything into account, HCTI scores 1 out of 10 in our fundamental rating. HCTI was compared to 39 industry peers in the Health Care Technology industry. HCTI has a bad profitability rating. Also its financial health evaluation is rather negative. HCTI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HCTI had negative earnings in the past year.
HCTI had a positive operating cash flow in the past year.
In multiple years HCTI reported negative net income over the last 5 years.
HCTI had negative operating cash flow in 4 of the past 5 years.
HCTI Yearly Net Income VS EBIT VS OCF VS FCFHCTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -208.83%, HCTI is doing worse than 91.89% of the companies in the same industry.
Industry RankSector Rank
ROA -208.83%
ROE N/A
ROIC N/A
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
HCTI Yearly ROA, ROE, ROICHCTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2019 2020 2021 2022 2023 0 1K -1K -2K

1.3 Margins

HCTI's Gross Margin of 25.14% is on the low side compared to the rest of the industry. HCTI is outperformed by 81.08% of its industry peers.
HCTI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HCTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
HCTI Yearly Profit, Operating, Gross MarginsHCTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2019 2020 2021 2022 2023 0 -20K -40K -60K -80K -100K

More info and screens

2

2. Health

2.1 Basic Checks

HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HCTI has been increased compared to 1 year ago.
Compared to 1 year ago, HCTI has a worse debt to assets ratio.
HCTI Yearly Shares OutstandingHCTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
HCTI Yearly Total Debt VS Total AssetsHCTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

HCTI has an Altman-Z score of -12.44. This is a bad value and indicates that HCTI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HCTI (-12.44) is worse than 86.49% of its industry peers.
The Debt to FCF ratio of HCTI is 1.14, which is an excellent value as it means it would take HCTI, only 1.14 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.14, HCTI is in the better half of the industry, outperforming 78.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.14
Altman-Z -12.44
ROIC/WACCN/A
WACC20.05%
HCTI Yearly LT Debt VS Equity VS FCFHCTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

2.3 Liquidity

HCTI has a Current Ratio of 0.29. This is a bad value and indicates that HCTI is not financially healthy enough and could expect problems in meeting its short term obligations.
HCTI's Current ratio of 0.29 is on the low side compared to the rest of the industry. HCTI is outperformed by 91.89% of its industry peers.
A Quick Ratio of 0.29 indicates that HCTI may have some problems paying its short term obligations.
The Quick ratio of HCTI (0.29) is worse than 91.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
HCTI Yearly Current Assets VS Current LiabilitesHCTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.99% over the past year.
Looking at the last year, HCTI shows a very negative growth in Revenue. The Revenue has decreased by -55.75% in the last year.
Measured over the past years, HCTI shows a small growth in Revenue. The Revenue has been growing by 1.94% on average per year.
EPS 1Y (TTM)24.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.08%
Revenue 1Y (TTM)-55.75%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Sales Q2Q%-68.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCTI Yearly Revenue VS EstimatesHCTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 20M 40M 60M
HCTI Yearly EPS VS EstimatesHCTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HCTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HCTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCTI Price Earnings VS Forward Price EarningsHCTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

HCTI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HCTI is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.37
EV/EBITDA N/A
HCTI Per share dataHCTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHCARE TRIANGLE INC

NASDAQ:HCTI (2/21/2025, 8:25:15 PM)

After market: 0.3971 +0 (+0.53%)

0.395

-0.11 (-21.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-15 2023-05-15/amc
Earnings (Next)N/A N/A
Inst Owners2.01%
Inst Owner Change-70.37%
Ins Owners0.54%
Ins Owner Change0%
Market Cap2.24M
Analysts82.86
Price TargetN/A
Short Float %1.76%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF 2.37
P/OCF 2.36
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.18
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.17
FCFY42.19%
OCF(TTM)0.17
OCFY42.33%
SpS2.92
BVpS-0.32
TBVpS-0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -208.83%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.14%
FCFM 5.7%
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
F-Score5
Asset Turnover3.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.14
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -12.44
F-Score5
WACC20.05%
ROIC/WACCN/A
Cap/Depr(3y)106.37%
Cap/Depr(5y)169.41%
Cap/Sales(3y)5.38%
Cap/Sales(5y)6.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.08%
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-55.75%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Sales Q2Q%-68.98%
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y109.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.08%
OCF growth 3YN/A
OCF growth 5YN/A